AzTrials
AzTrials

Mild Traumatic Brain InjuryTEaMNCT04576715

TBI Evaluation and Management (TEaM)

A study testing TEaM Intervention in people with Mild Traumatic Brain Injury, run by Emory University at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate a multi-disciplinary, multi-setting intervention with the goal of improving outcomes for children who have experienced a mild traumatic brain injury (mTBI). Read more about this study

Who is it for?
Ages 5 years and older
Conditions the study is for
Mild Traumatic Brain Injury
What is being tested?
TEaM Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
101 participants
Where
3 sitesUnited States
Study dates
19 Aug 2022to 14 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

PROVIDER INCLUSION CRITERIA

  • Actively practicing physician or APP in the CHOA System
  • Primary practice in either ED, UC, and/or PCP

PROVIDER EXCLUSION CRITERIA

  • Inability or unwillingness to provide written/electronic informed consent
  • Unable to fulfill study training / education requirements

CHILD INCLUSION CRITERIA - RETROSPECTIVE

  • School age (5-18 yoa)
  • Evaluated in ED / UC / PCP within 72 hours of injury
  • Discharged home from ED / UC / PCP (e.g., not admitted to hospital)

CHILD EXCLUSION CRITERIA - RETROSPECTIVE

  • Non-English speaking
  • Known severe developmental delay or known severe psychiatric history
  • Known prior severe brain injury
  • Known mTBI within past 3 months
  • First mTBI visit outside of CHOA network

CHILD INCLUSION CRITERIA - PROSPECTIVE

  • Meets above inclusion for retrospective portion plus:
  • mTBI likely present as defined by:
  • Positive diagnosis by clinician or mTBI OR
  • Positive triage screen plus positive symptom checklist

CHILD EXCLUSION CRITERIA - PROSPECTIVE

  • Does not meet above exclusion for retrospective portion plus:
  • Requests to Opt-Out via e-mail or first phone contact
  • Inability or unwillingness to provide verbal informed telephone consent/assent

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • Children's Healthcare of Atlanta (CHOA) - Egleston Emergency Department

    Atlanta, Georgia, 30322

  • Children's Healthcare of Atlanta- Forsyth, Northpoint and Town Center Urgent Care Centers

    Atlanta, Georgia, 30322

  • Children's Healthcare of Atlanta- Primary Care Offices

    Atlanta, Georgia, 30322

Other trials in United States

About this study

Official title: Promoting Recovery in Children Who Sustain a Mild Traumatic Brain Injury: mTBI Evaluation and Management (TEaM)

The purpose of this study is to evaluate a multi-disciplinary, multi-setting intervention with the goal of improving outcomes for children who have experienced a mild traumatic brain injury (mTBI). The project aims to improve and support mTBI diagnosis and management, and improve critical decision making by clinicians during their interaction with the injured child, their family, and their school.

Read the detailed description

Emergency, urgent care, and primary care providers participating in the study will be block randomized in a 1:1 ratio by practice type to receive the intervention or continue with their standard practice. All enrolled clinicians (both trained and control providers) patients they care for will be screened for inclusion in the trial.

Additionally, a pre/post intervention will be layered upon the randomized educational intervention to evaluate the effects of the information technology decision support tool (i.e. eMR) in isolation of the clinician education intervention. The 32-month mTBI patient enrollment period will be divided into two 16 months segments. The first 16 months will be without the eMR intervention being visible, and the remaining 16 months post eMR screening and decision support deployment in the ED and UC. This study design allows us to evaluate the independent and interactive effects of the decision support tool and educational intervention.

Enrolled children will be followed for up to three months post injury to ascertain the effect of the interventions on the primary aim (reduction of school problems/performance) and secondary aims.

Being tested
TEaM Intervention, Standard of Care
Keywords
mTBI, Brain injury, Emergency medicine, Urgent care, Primary care, Concussion, Pediatrics
Medical subject headings
Brain Concussion, Brain Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TEaM InterventionBehavioural

    Also called TEaM

    Multi-setting mTBI (mild traumatic brain injury) Evaluation and Management Intervention incorporates provider education and information technology support systems, based on the best available evidence and tailored to a specific environment (acute care setting vs primary care clinic). Facilitates linkages between providers (ED/UC to primary care) and systems (healthcare to school).

    • Provider Training Modules: Training includes decision-making support alerted by positive triage screening and concussion-specific eMR template
    • Management based on current best practices (however, may have additional education from the provider training)
    • Return to school letters
    • Primary Care Follow Up
  • Standard of CareBehavioural

    Continue with CHOA current best practices for mTBI:

    • No TEaM Provider training (but will be offered to all providers at end of study)
    • Will not be trained on utilization and implementation of the concussion screening alert and eMR template
Study groups in NCT04576715
Study groupRoleWhat they receive
TEaM Intervention GroupExperimentalDedicated Provider Education plus Information Technology Support. The IT support includes addition of an eMR concussion screening, followed by an alert to the provider, followed by a structured assessment / evaluation template.
Receives: Behavioral: TEaM Intervention
Control GroupActive comparatorStandard medical protocol for the management of mTBI in children. This group will not receive interventional Provider Training on the TEaM concussion evaluation examination and utilization of the eMR template.
Receives: Behavioral: Standard of Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in CLASS survey score

    Concussion Learning Assessment and School Survey (CLASS), identifies the types of problems students experienced across all grades. Total score range 0-42 (14 individual items rated 0-3, 0 = no problem, 3 = significant problem). Higher score reflects a greater problem/ worse outcome.

    Measured: 1 week, 2 week and 1 month post return to school

  2. Change in Post-concussion symptom inventory (PCSI) total score

    Change in Post-concussion symptom inventory (PCSI). Total score range, 0-24 (4 symptoms on a 0-6 scaling). Higher score reflects a greater problem/worse outcome.

    Measured: 1 week, 2 week and 1 month post return to school

  3. Change in Peds-QL score

    Pediatric Quality of Life (PedsQL) scale, includes 23 items, rated 0-4 (assesses different areas of function (physical, emotional, social, school) to determine if the child is having any problems with various tasks in each functional area and if so, how often the difficulty occurs).

    4 sub scales (general health 8 items 0-4 scaling, 0-32 total; social 5 items, 0-4 scaling, 0-20; school 5 items, 0-4 scaling, 0-20; emotional 5 items, 0-4 scaling, 0-20, 0=it is never a problem, 4= it is almost always a problem). Higher raw score reflects worse overall quality of life. Items are calculated and transformed into an overall score with a range of 0-to-100 points, with 100 points indicating better HRQoL.

    Measured: 1 week, 2 week and 1 month post return to school

  4. Post-concussion symptom inventory (PCSI) total score at 3 months post injury

    Persistent post-mTBI symptoms as measured by the PCSI total score at 3 months post injury.

    Total score range, 0-24 (4 symptoms on a 0-6 scaling). Higher score reflects a greater problem/worse outcome.

    Measured: 3 months post injury

  5. Time to return to full activity post injury

    Measured by serial PCSI and return to activity. PCSI Total score (PPCS-Persistent Post-Concussive Symptoms - will be calculated via the PCSI Total Score with scores classified as "Recovered" or "Non-Recovered (PPCS)" based on the Reliable Change Metrics that reflect recovery or not (e.g., for Parent and Adolescent PCSI Total RAPID score <5 indicates symptom recovery). Total score ranges from 0 to 100%. Lower % with PPCS in Intervention group compared to Control indicates better study outcome.

    Measured: Up to 3 months post-intervention

Secondary outcomes (2)
  1. Primary Care Physician (PCP) follow up visits

    Number of PCP visits for concussion during 3 month follow-up period.

    Measured: 3 months post-intervention

  2. Number of letters sent to school

    Number of Primary care Physician (PCP) letters sent to school within 2 weeks post-injury

    Measured: 2 weeks post-injury

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2020
  2. Study start19 Aug 2022
  3. Primary completion14 Nov 2025
  4. Study completion14 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
101 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04576715
Sponsor's protocol ID
IRB00108674
Other IDs
2025P011539
Acronym
TEaM
Status last verified
Mar 2026
First submitted
1 Oct 2020
Last updated
13 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: information about the protocol and SAP will be shared no earlier that one year after study closure.

Questions about this trial

What is this clinical trial studying?

A study testing TEaM Intervention in people with Mild Traumatic Brain Injury, run by Emory University at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in CLASS survey score (time frame: 1 week, 2 week and 1 month post return to school). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
TBI Evaluation and Management (TEaM) (NCT04576715) | AzTrials